MARKET

ABBV

ABBV

AbbVie
NYSE

Real-time Quotes | Nasdaq Last Sale

76.19
+0.95
+1.26%
After Hours: 74.45 -1.74 -2.28% 19:42 03/31 EDT
OPEN
75.40
PREV CLOSE
75.24
HIGH
77.92
LOW
74.44
VOLUME
20.48M
TURNOVER
--
52 WEEK HIGH
97.86
52 WEEK LOW
62.55
MARKET CAP
112.51B
P/E (TTM)
14.43
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ABBV stock price target is 94.00 with a high estimate of 106.00 and a low estimate of 70.00.

EPS

ABBV News

More
  • AbbVie Donates $35 Million for COVID-19 Relief to Support Healthcare Systems, Patients and Communities
  • PR Newswire · 5h ago
  • Buy this High-Yield Large Cap Pharma Stock for Income Amid Coronavirus
  • Zacks · 6h ago
  • AbbVie (ABBV) Gains As Market Dips: What You Should Know
  • Zacks · 6h ago
  • 19 Dividend Aristocrats That Have Gone on Deep Discount
  • Kiplinger · 8h ago

Industry

Pharmaceuticals
-0.13%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About ABBV

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
More

Webull offers kinds of AbbVie Inc stock information, including NYSE:ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions.